Ad is loading...
MENU

CERO Stock Tickeron detected bearish Stock Pattern: Cup-and-Handle Inverse CERO on July 29, 2024, netting in a 27.30% gain over 7 days

A.I.dvisor
at Tickeron.com
Loading...
+27.30% Gain from a Successful pattern Cup-and-Handle Inverse
CERO - CERo Therapeutics Holdings
Tickeron
Ticker: CERO
Company: CERo Therapeutics Holdings
Gain from shortening: +27.3%
Confirmed: 07/29/24
Succeeded: 07/31/24
Total length: 7 days
On July 24, 2024, A.I.dvisor detected a Cup-and-Handle Inverse Pattern (Bearish) for CERo Therapeutics Holdings (CERO, $0.21). 5 days later, on July 29, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On July 31, 2024, the stock hit the target price of $0.14 – resulting in a +2 gain for traders who shorted the stock on the pattern detection date.

CERO's Indicator enters downward trend

The Aroon Indicator for CERO entered a downward trend on November 08, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 86 similar instances where the Aroon Indicator formed such a pattern. In of the 86 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CERO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CERO broke above its upper Bollinger Band on November 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 35 cases where CERO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 11, 2024. You may want to consider a long position or call options on CERO as a result. In of 51 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CERO just turned positive on November 11, 2024. Looking at past instances where CERO's MACD turned positive, the stock continued to rise in of 28 cases over the following month. The odds of a continued upward trend are .

CERO moved above its 50-day moving average on November 11, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CERO crossed bullishly above the 50-day moving average on November 12, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +28 3-day Advance, the price is estimated to grow further. Considering data from situations where CERO advanced for three days, in of 45 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.849). P/E Ratio (0.000) is within average values for comparable stocks, (95.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). CERO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (211.128).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CERO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CERO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CERO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Haskings Way
Phone
+1 215 731-9450
Employees
9
Web
https://www.cero.bio